Haima receives NSF SBIR funding
Haima Therapeutics receives the National Science Foundation’s Small Business Innovation Research Program Phase 1 funding to continue the development of SynthoPlate.
Haima Therapeutics receives the National Science Foundation’s Small Business Innovation Research Program Phase 1 funding to continue the development of SynthoPlate.
Michaela Cooley has graduated from her BME program and joined the MSTP program at Case Western Reserve University. Congratulations, Michaela!